Biocon acquires Eywa Pharma's US-based plant for USD 7.7 mn https://ift.tt/tzGuLhK

The facility is acquired for a total consideration of USD 7.7 million, it added. As part of the acquisition, the existing workforce of the facility will transition into Biocon Generics Inc. The facility has the potential for capacity expansion of up to 2 billion tablets/capsules per year.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/LY6Fuat
Share:

Related Posts:

No comments:

Post a Comment

Search This Blog

Powered by Blogger.

Labels

Unordered List

  • Lorem ipsum dolor sit amet, consectetuer adipiscing elit.
  • Aliquam tincidunt mauris eu risus.
  • Vestibulum auctor dapibus neque.

Pages

Theme Support

Need our help to upload or customize this blogger template? Contact me with details about the theme customization you need.